Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson's disease in Shanghai

Chinese Journal of Medical Genetics

Volumn 25, Issue 3, 2008, Pages 272-275

  Hao, Yi Xin ^a   Zhang, Jun ^a   Fang, Chao Ping ^a   Zhang, Qian ^a   Zhang, Jian Rong ^a   Shen, Qian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene; Genetic polymorphism; Parkinson's disease; Ubiquitin carboxy terminal hydrolase L1

Indexed keywords

PHENYLALANINE; SERINE; TYROSINE;

ARTICLE; CHINA; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTATOR GENE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1 GENE;

ADULT; AGED; AGED, 80 AND OVER; CHINA; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; UBIQUITIN THIOLESTERASE;

EID: 46749123919     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature, 1998,395:451-452.
2. The extrapyramidal disease conference in China. Diagnostic criteria and differential diagnosis of Parkinson' disease and Parkinson's syndrome. Chin J Neuro, 1985,18:256.
3. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science, 2003,302:819-822.
4. Osaka H, Wang YL, Takada K, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet, 2003, 12:1945-1958.
5. Maraganore DM, Farrer MJ, Hardy JA, et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology, 1999,53:1858-1860.
6. Wintermeyer P, Kruger R, Kuhn W, et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport, 2000,11:2079-2082.
7. Momose Y, Murata M, Kobayashi K, et al. Association studies of multiple candidate genes for Parkinson s disease using single nucleotide polymorphism. Ann Neurol, 2002,51:133-136.
8. Tan EK, Puong KY, Fook-Chong S, et al. Case-control study of UCHL1 S18Y variant in Parkinson's disease. Mov Disord, 2006,21:1765-1768.
9. Healy DG, Abou-Sleiman PM, Wood NW. Genetic causes of Parkinson's disease: UCHL-1. Cell Tissue Res, 2004,318:189-194.
10. Nishikawa K, Li H, Kawamura R, et al. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem Biophys Res Commun, 2003,304:176-183.
11. Liu Y, Lashuel HA, Choi S, et al. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem Biol, 2003,10:837-846.